Rivaroxaban

Once-daily selective direct factor Xa inhibitor for stroke prevention, VTE prophylaxis and treatment. Non-inferior to warfarin in ROCKET AF trial for atrial fibrillation with stroke risk.

Mechanism of action

Selectively inhibits factor Xa in prothrombin activation complex, preventing thrombin generation and clot formation. Rapid oral absorption with once-daily convenient dosing.

This page is restricted. Please Login / Register to view this page.

Mechanism of action

Selectively inhibits factor Xa in prothrombin activation complex, preventing thrombin generation and clot formation. Rapid oral absorption with once-daily convenient dosing.

This page is restricted. Please Login / Register to view this page.

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Rivaroxaban

Direct Factor Xa inhibitor (Novel Oral Anticoagulant - NOAC)

Description

Mechanism of action

Mechanism of action

Follow us: